Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

electroCore, Inc. Director's Dealing 2018

Jun 22, 2018

34720_dirs_2018-06-22_bde9026e-20bc-40de-af07-97f06e3a21e6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: electroCore, Inc. (ECOR)
CIK: 0001560258
Period of Report: 2018-06-21

Reporting Person: Merck Global Health Innovation Fund, LLC (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-06-21 Common Stock P 166666 $15 Acquired 3346032 Direct